HIRANO MASAAKI
No ORCID on file
· 91 papers in corpus
· active 2005-2011
Frequent coauthors
- SUZUMURA KENICHI 49
- KONDOH YUTAKA 49
- NIIMI TATSUYA 49
- KAKEFUDA AKIO 49
- FURUTANI TAKASHI 49
- YAMAGUCHI TOMOHIKO 49
- ENJO KENTARO 49
- AMANO YASUSHI 49
- KINOYAMA ISAO 42
- KAWAMINAMI EIJI 42
2011
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2011
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2011
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2011
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2011
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2011
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2011
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…
2010
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breas…
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …
2010
Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …